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Article focus
  The current article uses a genetically 
modified mouse model (Phospho1-/-) to 
study the effects of poor bone mineraliza-
tion on bone fracture healing.
Key messages
  The amount of unmineralized bone is mark-
edly higher at fracture sites in Phospho1-/- 
mice than that of wild type mice.
Strengths and limitations
  The use of PHoSPHo1 as a pro-minerali-
zation agent may facilitate faster minerali-
zation and healing of fractures.
Introduction
Fractures are common and fracture healing 
is a complex process, regulated by genetic, 
biological and mechanical factors, which 
takes place over a period of weeks to years. 
Fracture healing may occur through intra-
membranous ossification, but more com-
monly, through endochondral ossification, 
which is typically seen in long bone 
fractures.1-4
Bone forming osteoblasts play a key role 
in the fracture healing process by regulating 
the mineralization of the bone extracellular 
matrix (ECM). A poorly mineralized ECM 
may lead to improper resorption of the 
pHospHo1 is essential for normal  
bone fracture healing
AN ANIMAl STUDY
Objectives
Bone fracture healing is regulated by a series of complex physicochemical and biochemi-
cal processes. one of these processes is bone mineralization, which is vital for normal bone 
development. phosphatase, orphan 1 (pHospHo1), a skeletal tissue-specific phosphatase, 
has been shown to be involved in the mineralization of the extracellular matrix and to main-
tain the structural integrity of bone. In this study, we examined how pHospHo1 deficiency 
might affect the healing and quality of fracture callus in mice.
Methods
Tibial fractures were created and then stabilized in control wild-type (WT) and Phospho1-/- 
mice (n = 16 for each group; mixed gender, each group carrying equal number of male and 
female mice) at eight weeks of age. Fractures were allowed to heal for four weeks and then 
the mice were euthanized and their tibias analyzed using radiographs, micro-cT (μcT), his-
tology, histomorphometry and three-point bending tests.
Results
The μcT and radiographic analyses  revealed a mild reduction of bone volume in Phospho1-/- 
callus, although it was not statistically significant. An increase in trabecular number and a 
decrease in trabecular thickness and separation were observed in Phospho1-/- callus in com-
parison with the WT callus. Histomorphometric analyses showed that there was a marked 
increase of osteoid volume over bone volume in the Phospho1-/- callus. The three-point bend-
ing test showed that Phospho1-/- fractured bone had more of an elastic characteristic than 
the WT bone.
Conclusion
our work suggests that pHospHo1 plays an integral role during bone fracture repair and 
may be a therapeutic target to improve the fracture healing process.
cite this article: Bone Joint Res 2018;7:397–405.
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 mineralized callus and eventually to weaker bone with 
compromised mechanical properties.
Bone mineralization is regulated by both humoral and 
cellular factors that are produced locally in the tissue. 
Humoral factors include inorganic phosphate (Pi) and cal-
cium ions, as well as the hormones that regulate their 
homeostasis.5,6 The deposition of hydroxyapatite (HA) crys-
tals (Ca10(Po)4(oH)2) in bone significantly contributes to its 
unique mechanical and biophysical properties.7 osteoblasts 
regulate ECM mineralization by synthesizing the mineral-
scaffolding matrix and producing enzymes that control the 
nucleation and propagation of mineral crystals.8
An essential component in the regulation of bone 
ECM mineralization is alkaline phosphatase and in par-
ticular, tissue non-specific alkaline phosphatase (TNAP/
AlPl), which is encoded by the ALPL gene.9 TNAP is a 
membrane-bound glycoprotein that is present on the 
surface of mineralizing cells such as osteoblasts.10 It plays 
an important role in maintaining the extracellular con-
centration of inorganic pyrophosphatase (PPi), a potent 
inhibitor of ECM mineralization. TNAP splits PPi into Pi, an 
essential component of HA, which in turn facilitates the 
formation and propagation of HA crystals.11,12 Mutations 
in ALPL can lead to severe impairment of bone and teeth 
mineralization in humans and in experimental mod-
els.12,13 We have recently shown that during embryonic 
development, AlPl and a cytosolic phosphatase, Phos-
phatase, orphan 1 (PHoSPHo1), work cooperatively to 
facilitate skeletal tissue mineralization.10,14,15
PHoSPHo1 is a member of the haloacid dehalogenase 
(HAD) superfamily of magnesium (Mg2+)-dependent 
hydrolases. It splits phosphoethanolamine (PE) and phos-
phocholine to produce ethanolamine or choline and Pi.16,17 
The expression of PHoSPHo1 is at least 100-fold higher in 
mineralized tissues and has been detected in multiple spe-
cies including in humans and mice.18-20 Several studies 
have examined the phenotype of PHoSPHo1-deficient 
(Phospho1-/-) mice and found that these mice show abnor-
mal endochondral growth plates and skeletal anomalies 
including osteomalacia, scoliosis, long bone deformity 
and spontaneous fractures.15,21,22 These findings suggest 
that PHoSPHo1 is an essential regulator of skeletal tissue 
development and maintenance.
The role of PHoSPHo1 in bone fracture healing and 
the mechanical properties of the newly formed bone 
have not been reported previously. Based on our knowl-
edge of the essential role of PHoSPHo1 in bone minerali-
zation, we hypothesize that it plays a critical role in 
fracture healing. our results presented here show that 
PHoSPHo1 activity is necessary during the repair of frac-
tured bones.
Materials and Methods
Mice. Generation of Phospho1-/- mice has been described 
previously.21 Eight-week-old Phospho1-/- mice and 
wild-type (WT) control mice were used for this study. All 
mice were generated and maintained at the Shriners ani-
mal facility following a protocol approved by the Animal 
Care and Use Committee of McGill University.
Surgical method. All mice underwent intramedullary 
nailing of the right tibia at eight weeks of age. A total 
of 32 mice (16 WT and 16 mutant mice, mixed gender, 
each group carrying equal number of male and female 
mice) were used. The surgical procedure was performed 
under aseptic conditions in the procedure room of the 
animal facility. The mice were anaesthetized with an 
isoflurane-oxygen gas mix and kept under anaesthesia 
throughout the length of the procedure. A 3-mm ver-
tical skin incision was made at the knee and the patel-
lar ligament was exposed. The joint line was identified, 
and a 26 G needle was inserted into the proximal tibial 
canal. The internal wire guide of a 25 G spinal needle 
was then passed through the 26 G needle and down 
the tibial canal. The 26 G needle was removed leaving 
the wire within the tibia and the wire was then cut short 
at the level of the tibial plateau. Through the same skin 
incision, a mid-shaft tibial osteotomy was produced with 
extra fine Bonn scissors (Fine Science Tools, Foster City, 
California). The soft tissues were closed with a single 6-0 
vicryl suture and the animals were returned to their cage 
to recover. Post-operative care included a subcutane-
ous injection of carprofen (5 μl/g) and 20 μl/g of normal 
saline. The mouse cage was placed on a heated pad and 
the mice were allowed to ambulate freely. The animals 
were closely monitored and any mice showing signs of 
severe pain, bleeding or swelling were humanely killed.
Sample collection. The analysis of the fractured bones 
was performed four weeks after surgery. The mice were 
euthanized, fractured legs were dissected out and the 
intramedullary nail from the tibia was carefully removed 
with a needle holder. Tibias destined for micro-CT (μCT) 
and histological analysis were fixed in buffered formalin 
overnight and then transferred to 70% ethanol, whilst 
the tibias destined for mechanical testing were wrapped 
in paper and stored in phosphate-buffered saline at 4°C 
until biomechanical testing. Sample distribution for vari-
ous analyses was as follows: μCT, n = 8 mice/group; 
radiographs, n = 3 mice/group; histology and histomor-
phometry, n = 8 mice/group; and three-point bending 
test, n = 8 mice/group.
Radiographs. Imaging of the tibias was performed using 
the XPERT radiograph imaging system (Kubtec Medical 
Imaging, Stratford, Connecticut). The radiograph source 
was operated at 21 kv and at 550 μA. Samples were 
scanned at a magnification of ×4.
μCT. Tibia samples in 70% ethanol were subjected to 
μCT analysis (SkyScan 1172 radiograph micro-tomo-
graph; Skyscan, Kontich, Belgium). All scans were 
undertaken with the SkyScan 1.5 software at a source 
voltage of 65  kv and a source current of 153 μA. A 
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medium camera setting with an aluminium filter was 
used. The samples were scanned at an image voxel size 
of 5 μm with a mean scanning time of 30 minutes for 
each sample. For every 0.45° of sample rotation, three 
image frames were retained. A total vertical segment 
of 8 mm was scanned for every sample and generated 
around 800 consecutive transverse image slices. The 
generated images were reconstructed using cone-beam 
reconstruction software (SkyScan) with a beam-hard-
ening correction of 50% and a ring artefact correction 
of 5%. The reconstructed images were then analyzed 
using SkyScan 1.11 software.
Histology and histomorphometry. For plastic sectioning, 
tibia samples were fixed overnight in 10% buffered for-
malin, pH 7.4, embedded in methyl methacrylate, and 
sectioned (7 μm thickness). Sections were deplasticized 
in 2-methoxyethyl acetate and rehydrated in a descend-
ing series of alcohols. The sections were stained with 
von Kossa, followed by van Gieson, staining to detect 
the mineralized and unmineralized ECM, respectively. 
Briefly, the slides were first immersed in 1% silver nitrate 
for five minutes, washed in deionized water, immersed in 
5% sodium carbonate in 10% formaldehyde for five min-
utes, washed in running tap water and finally placed in 
5% sodium thiosulfate for five minutes and again washed 
in running tap water. Next, the slides were stained in van 
Gieson solution (0.25% fuchsin in 10% glycerol, 0.35% 
nitric acid and 90% picric acid) for two minutes and dehy-
drated in an ascending series of alcohols and mounted 
using a xylene-based mounting solution. For the detec-
tion of osteoblasts, deplasticized and rehydrated sections 
were stained with 1% toluidine blue, pH 4.5, for one min-
ute. For the detection of the osteoclasts, deplasticized and 
rehydrated sections were stained for the tartrate-resistant 
acid phosphatase activity. The sections were incubated 
with the substrate, 0.02% naphthol AS-BI phosphate 
solution, for 30 minutes under acidic conditions. Next, 
sodium nitrite (0.08% final concentration) and pararos-
aniline dye solution (0.08% final concentration) were 
added to the substrate solution containing the slides 
and left for ten minutes until the osteoclasts developed 
the characteristic red stain. Slides were counterstained 
with Carazzi’s haematoxylin, washed in water and 
mounted using an aqueous medium. Stained bone sec-
tions were analyzed for bone volume/tissue volume (Bv/
Tv), osteoid volume/bone volume (ov/Bv), osteoblast 
and osteoclast count using the osteomeasure software 
(osteometrics Inc., Atlanta, Georgia). The region of inter-
est was selected within the fracture healing site. Images 
were taken at room temperature using a light micro-
scope (DM200; leica, Wetzlar, Germany). All histologi-
cal images were captured using a camera, acquired with 
DP2-BSW software (Xv3.0; olympus, Tokyo, Japan) and 
processed using Photoshop (Adobe, San Jose, California).
three-point bending test. The stored bone samples were 
equilibrated at room temperature and placed on fulcra 
5 mm apart. An axial load from above was applied on 
the fracture site between the two fulcra. The load was 
applied at a rate of 5 mm/minute until the bone break-
age. This test was done using a universal three-point 
bending machine (Instron, Norwood, Massachusetts).
Statistical analysis. All statistical analyses were performed 
using SPSS software version 20 (IBM, Armonk, New 
York). Statistical analyses were performed by Student’s 
t-test with p < 0.05 considered statistically significant. A 
single asterisk indicates p < 0.05, double asterisks indi-
cate p < 0.001 and triple asterisks indicate p < 0.0001.
Results
Study design and surgery. outlines of the study design 
and the surgical procedure have been depicted in 
Figure 1.
Radiographic analysis. The radiograph analyses pro-
vided the first line of evidence that PHoSPHo1 deficiency 
affected bone fracture healing. As shown in Figure 2a, 
WT fractured tibia showed a normal reduction of callus 
size four weeks after fracture, indicating that the formed 
callus had been remodelled and the tibia had returned 
to its uniform shape. on the other hand, the Phospho1-/- 
tibia showed the presence of a large callus indicative of 
delayed remodelling, suggesting that the fractured bone 
had not regained its original shape by the time of analysis.
μCt analyses. The cross-sectional μCT images of the WT 
and Phospho1-/- callus showed significant differences in 
both the shape and architecture of the bone at the frac-
ture site (Fig. 2b). The WT tibia showed organized thick 
cortices with less trabecular bone in contrast to the 
Phospho1-/- callus that showed very thin cortices with an 
abundance of disorganized trabeculae.
The mean bone volume at the fracture site was found 
to be slightly higher in the WT (6.79 sd 0.58) than in the 
Phospho1-/- group (5.47 sd 0.71) although this was not 
significant (Student’s t-test: p = 0.175) (Fig. 2c). Similarly, 
the percentage ratio of bone volume to tissue volume 
that was calculated for each group was found to be com-
parable in the WT (51.43 sd 0.177) and in the Phospho1-/- 
group (50.34 sd 2.9), without any significant differences 
(Student’s t-test: p = 0.757) (Fig. 2d).
We also investigated other properties of the newly 
formed trabecular bone in the callus. The trabecular thick-
ness and separation was significantly higher in the WT 
group (0.13 sd 0.003 and 0.22 sd 0.02) than in the 
Phospho1-/- group (0.09 sd 0.01 and 0.16 sd 0.02; p = 
0.008 and p = 0.03, respectively) (Figs 2e and 2f). In con-
trast, the trabecular numbers were found to be significantly 
increased in the Phospho1-/- mice (5.70 sd 0.75) in compari-
son with WT mice (3.82 sd 0.18; p = 0.03) (Fig. 2g).
Histology and histomorphometric analyses. Histological 
analysis of the von Kossa-van Gieson-stained sections 
showed that the WT callus was more homogeneous with 
uniform cortices with minimal amounts of osteoid and 
trabecular bone (Fig. 3a). After visual comparison of the 
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fractured bone sections in each group, there appeared to 
be an increase in the osteoid volume and surface area in 
the Phospho1-/- group. In addition, the callus appeared 
less organized and the cortices were poorly defined. At 
higher magnifications (Figs 3b and 3c), we observed 
an abundant amount of disorganized osteoid in the 
Phospho1-/- callus compared with the minimal amounts 
of evenly distributed osteoid in the WT callus.
To further confirm these observations, histomorpho-
metric analyses were performed. The osteoid surface/
bone surface (oS/BS) and ov/Bv were measured in both 
groups. Both oS/BS and ov/Bv in the Phospho1-/- group 
were significantly higher (34.82 sd 4.83 and 11.18 sd 
0.68; p = 0.007) than in the WT group (7.74 sd 2.1 and 
1.10 sd 0.12; p = 0.0001) (Fig. 4a).
The number of osteoblasts and osteoclasts per tissue 
area (N.ob/T.Ar, N.oc/T.Ar), and osteoblast and osteo-
clast surface per bone surface (ob.s/BS, oc.s/BS) were 
determined and the Phospho1-/- group showed a signifi-
cant increase in osteoblast numbers in both the tissue 
(N.ob/T.Ar) and on the bone surface (ob.s/BS) when 
compared with the WT group (p = 0.018 and p = 0.006, 
WT
(n = 16)
Radiograph ( n = 3)
μCT (n = 8)
Histomorphometry
(n = 8)
3-point bending
(n = 8)
IMN at 8 weeks
Euthanasia
at 4 weeks
post-operative
Phospho1-/-
(n = 16)
Radiograph ( n = 3)
μCT (n = 8)
Histomorphometry
(n = 8)
3-point bending
(n = 8)
IMN at 8 weeks
Euthanasia
at 4 weeks
post-operative
Outline
Fig. 1a
Fig. 1b
a) Scheme showing the study design. b) intramedullary nails (IMN) were inserted into the right tibia of eight-week-old (8w) wild-type (WT) and Phospho1-/- 
mice, which were then fractured. Mice were analyzed after four weeks (4w) of surgery by radiography, micro-CT (µCT), histomorphometry and three-point 
bending tests; steps of intramedullary fracture surgery of the tibia.
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Fig. 2a Fig. 2e
Fig. 2b
Fig. 2dFig. 2c
Fig. 2f
Fig. 2g
a) Radiographs of the fractured right tibia. There was an increase in callus size in Phospho1-/- fractured bone in comparison with wild-type (WT) bone; b) 
micro-CT (µCT) images of the site of fracture of the right tibia in WT and Phospho1-/- mice. WT fracture showed thick cortical walls with normal trabecular bone 
structure. Phospho1-/- fracture showed thin cortical walls and disorganized trabecular bones; c) and d) analysis of μCT data showed that there was no significant 
difference in total bone volume and bone volume/tissue volume (Bv/Tv) between WT and Phospho1-/- mice; e) and f) µCT analysis showed a significant decrease 
in the trabecular thickness and trabecular separation in Phospho1-/- fractured bone; g) trabecular numbers were significantly increased in Phospho1-/- fractured 
bones in comparison with WT fractured bones (NS, not significant).
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respectively) (Fig. 4b) but osteoclast numbers were not 
significantly different between the two groups (p = 0.25 
for both measurements) (Fig. 4c).
Mechanical analysis (three-point bending test). The 
mechanical properties of the fracture callus in the two 
groups was investigated. Three-point bending analy-
sis showed that in the Phospho1-/- group, there was sig-
nificantly more plastic deformation (load at yield) and a 
higher load to failure (maximum load) (Figs 5a and 5b) and 
this was statistically significant between the two groups 
(p = 0.014 and p = 0.009, respectively). In addition, the 
work required to reach this deformity and maximum load 
was significantly greater in the Phospho1-/- group (p = 0.02 
and p = 0.04, respectively) (Figs 5c to 5e).
Discussion
Fracture union closely reflects the embryonic develop-
ment of skeletal tissues, with a sequence of steps that 
require both systemic and local factors as well as 
coordinated functions of three cell types: chondrocytes 
and osteoblasts of mesenchymal origin, and osteoclasts 
from the hematopoietic lineage.4,23 The activities of these 
cells are directly associated with ECM mineralization as 
both chondrocytes and osteoblasts are involved in the syn-
thesis and mineralization of the organic matrix in the newly 
synthesized cartilage and bone, respectively, while osteo-
clasts resorb the mineralized ECMs in both of these tis-
sues.24,25 These cellular activities ultimately shape the 
architecture of the mineralized tissue at the fracture site 
and determine its biomechanical properties.
ECM mineralization, a specialized feature of skeletal 
tissues, is the basis of its unique physical and mechanical 
properties. Poor bone mineralization can result in skeletal 
deformities, which can in turn result in a variety of debili-
tating conditions.26 Although poorly mineralized bone 
has been identified as a risk factor for pathological frac-
tures, the effect of impaired mineralization on fracture 
healing has not been thoroughly studied.
While the effects of bone mineralization status on frac-
ture healing is poorly understood, it has been shown that 
in elderly patients with bone fractures, vitamin D com-
bined with dietary phosphate supplementation will pro-
mote the healing process.27 Considering that the 
pro-mineralization effects of this treatment help fracture 
healing, we hypothesized that impaired cartilage and/or 
bone mineralization would have an adverse effect on 
fracture healing. To investigate this further, we have used 
a genetic model of osteomalacia that lacks PHoSPHo1, a 
phosphatase that functions predominantly in the miner-
alizing skeletal cells.
At present, the mode of action of PHoSPHo1 in the reg-
ulation of ECM mineralization is not well understood. The 
osteomalacia seen in Phospho1-/- mice is not caused by a 
systemic reduction of Pi or calcium levels, suggesting that 
PHoSPHo1 deficiency affects local cell-intrinsic factors that 
may be responsible for the observed phenotype.28,29 It has 
been suggested that PHoSPHo1 activity is required for the 
initiation of hard tissue mineralization within the matrix 
vesicles (Mvs), small membrane-enclosed bodies that are 
released by the mineralizing cells to provide a protected 
microenvironment for initial mineral crystal nucleation.29 
PHoSPHo1 activity within the Mvs may increase the levels 
of Pi, triggering its precipitation as calcium phosphate salts. 
In support of this hypothesis, it has been shown that 
PHoSPHo1 is present and active in Mv preparations,16,29-32 
and in addition, PHoSPHo1 is also required for the miner-
alization of the Mvs.15
Reported literature and our unpublished data clearly 
show that PHoSPHo1 deficiency has an adverse effect on 
both cartilage and bone mineralization in endochondral 
ossification15,21 and, therefore, we decided to use this 
mouse model to investigate fracture healing of the tibia 
with stabilization of the fracture with an intramedullary 
pin, a widely used technique to study fracture healing via 
endochondral ossification.
Fig. 3c
Microscopic images of tibia sections showing the fracture site. The sections 
were stained as per von Kossa and van Gieson, which stains unmineralized 
bone pink and mineralized bone black: a) wild-type (WT) sections show-
ing normal fracture healing with a minimal amount of trabecular bone and 
evenly distributed osteoid. on the other hand, the Phospho1-/- fracture sec-
tions showed increased trabecular number and the osteoid formation. Panels 
(b) and (c) show the magnified view of the fractured bone sections.
Fig. 3a
Fig. 3b
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Although μCT analyses did not show a difference in 
bone volume at the fracture site between the two groups, 
with histomorphometric analysis, we were able to dem-
onstrate a higher osteoid volume in the Phospho1-/ - frac-
ture sites. Apart from the cell-intrinsic mineralization 
defects, other possible explanations of this increase in 
osteoid volume at the fracture site of the mutant mice 
could be the combined effects of localized increase of 
bone formation by osteoblasts and the impaired 
osteoclast resorption of the unmineralized bone matrix. 
Indeed, this is supported by our observation that osteo-
blast numbers were higher in Phospho1-/- fracture sites, 
whilst osteoclast numbers were unchanged as compared 
with the WT fracture group. It has been reported that the 
unmineralized bone matrix does not remodel due to 
impaired resorption of the matrix by osteoclasts.33-35 We 
believe that the increased synthesis of unmineralized 
bone and its poor resorption cause a significant delay in 
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Fig. 4a
Fig. 4b
Fig. 4c
a) Histomorphometry on von Kossa and van Gieson-stained slides shows that there is a statistically significant increase in osteoid surface/bone surface (oS/BS) 
and osteoid volume/bone volume (ov/Bv) in Phospho1-/- fractured bone sections; b) analysis of toluidine blue-stained sections showed a significant increase in 
the osteoblast count and surface area in Phospho1-/- fracture sites; c) analysis of tartrate-resistant acid phosphatase-stained sections showed that there was no 
statistically significant difference in the osteoclast count between the two groups (N.ob, number of osteoblasts; T.Ar, tissue area; ob.s, osteoblast surface; N.oc, 
number of osteoclasts; oc.s, osteoclast surface).
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bone remodelling in the Phospho1-/- callus, resulting in 
inadequate fracture healing and weaker bone.
Three-point bending tests allowed us to investigate 
the mechanical properties of the fractured tibia. In nor-
mally mineralized bone, the load at yield (load required 
to produce permanent deformation of the bone) will be 
close to the maximal load (load to bone failure) and this 
will result in limited plastic deformation of the bone. In 
contrast, in poorly mineralized bone, there is a larger dif-
ference between these two mechanical properties and 
this will result in greater plastic deformation before frac-
ture.36,37 Callus will have different biomechanical proper-
ties at various stages of the fracture healing process. In 
the early stages of callus development, it will have limited 
strength but as the callus progressively matures, the 
strength and stiffness increases.38,39
In this study, we analyzed the bones at four weeks 
after fracture surgery, which is the normal length of time 
required for the fracture to heal in mice.40 After four 
weeks, healed bone would be expected to be biome-
chanically competent. our analysis showed that 
Phospho1-/- healed bones would tolerate greater loads 
before plastic deformation or ultimate failure in compari-
son with the WT healed bones. This increased elasticity of 
the newly formed PHoSPHo1-deficient callus can be 
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0.0012
Fig. 5d
a) Phospho1-/- fractured bones required more load in order to break than the wild-type (WT) fractured bones; b) a significantly higher load was needed to cause 
a plastic deformity in the Phospho1-/- bone (load at yield) than in the WT bone; c) to e) overall, Phospho1-/- fractured bones needed more energy to deform and 
break in comparison with WT fractured bones as the former can sustain higher elastic and plastic deformities.
explained by the increased amount of unmineralized 
bone compared with the mineralized bones found in the 
WT callus. In addition, this finding is consistent with the 
greenstick fracture in Phospho1-/- mice and pathological 
fractures that have been reported.15
In conclusion, our study has shown that PHoSPHo1 
produced by bone-forming osteoblasts plays a key role in 
the normal bone fracture healing and in the formation of 
mechanically competent callus. We believe that this 
study has contributed to the existing body of knowledge 
about the role of PHoSPHo1 in bone mineralization and 
fracture healing. Further studies are needed to determine 
the clinical implications of these findings and whether 
PHoSPHo1 can be used as a therapeutic agent in the 
treatment of poorly mineralized fractured bone.
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